mRNA-Lipid Nanoparticle (LNP) Delivery of Humanized EpCAM-CD3 Bispecific Antibody Significantly Blocks Colorectal Cancer Tumor Growth
Vita Golubovskaya(Promega (United States)), Lijun Wu(Promega (United States))
Cited by 28
Related Papers
Targeting FAK in human cancer: from finding to first clinical trials
|Frontiers in bioscience|2014|201